Effects of miR-101 on EZH2 have been observed in various cancers [125], and downregulation of this microRNA and elevation of EZH2 have been found in NSCLC tumor tissues, prostate cancer, and renal cancer [110–112]. Here, EZH2 is linked to non-small cell lung carcinoma.